Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/4035

TDMS Study 05121-99 Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE


NTP Experiment-Test: 05121-99                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 03/15/95
Route: GAVAGE                                                                                                     Time: 17:07:00


                                                 05121/07 - 05121/08 COMPARISON


       Facility:  BATTELLE COLUMBUS LABORATORY

       Chemical CAS #:  6533-68-2

       Lock Date:  06/01/92

       Cage Range:  All

       Reasons For Removal:    25022 Accidently Killed                 25018 Dosing Accident
                               25019 Moribund Sacrifice                25020 Natural Death
                               25021 Terminal Sacrifice

       Removal Date Range:     All

       Treatment Groups:       Include 001    0 MG/KG
                               Include 002    0 MG/KG
                               Include 003    RTD     0 MG/KG
                               Include 005    RTD     0 MG/KG


























a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05121-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 03/15/95  
Route: GAVAGE                                                                                                     Time: 17:07:00  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      RTD                                                                 
                                                                0 MG/KG                                                             
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          70           60                                                               
  Early Deaths                                                                                                                      
    Natural Death                                      7            1                                                               
    Moribund Sacrifice                                 9            2                                                               
    Dosing Accident                                    2                                                                            
  Survivors                                                                                                                         
    Terminal Sacrifice                                33           47                                                               

  Animals Examined Microscopically                    51           50                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (51)         (50)                                                             
      Perforation                                      1 (2%)                                                                       
      Periesophageal Tissue, Inflammation,                                                                                          
          Suppurative                                  3 (6%)                                                                       
   Intestine Small, Jejunum                           (51)         (50)                                                             
      Hyperplasia, Lymphoid                            2 (4%)                                                                       
   Liver                                              (51)         (50)                                                             
      Angiectasis                                      1 (2%)       1 (2%)                                                          
      Basophilic Focus                                 1 (2%)       1 (2%)                                                          
      Eosinophilic Focus                              17 (33%)                                                                      
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Mixed Cell Focus                                 6 (12%)      2 (4%)                                                          
      Centrilobular, Necrosis                                       1 (2%)                                                          
      Serosa, Pigmentation, Hemosiderin                             1 (2%)                                                          
   Mesentery                                          (7)          (2)                                                              
      Fat, Necrosis                                    6 (86%)                                                                      
   Pancreas                                           (51)         (50)                                                             
      Atrophy                                          5 (10%)                                                                      
      Hypertrophy                                      1 (2%)                                                                       
      Acinus, Hyperplasia, Focal                                    3 (6%)                                                          
      Duct, Cyst                                       2 (4%)                                                                       
   Salivary Glands                                    (51)         (50)                                                             
      Duct, Hyperplasia                                1 (2%)                                                                       
   Stomach, Forestomach                               (51)         (50)                                                             
      Erosion                                                       1 (2%)                                                          
      Hyperplasia, Focal                               6 (12%)     29 (58%)                                                         
      Infiltration Cellular, Mast Cell                              1 (2%)                                                          
   Stomach, Glandular                                 (51)         (50)                                                             
      Erosion                                          2 (4%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    2                                                              
NTP Experiment-Test: 05121-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 03/15/95  
Route: GAVAGE                                                                                                     Time: 17:07:00  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      RTD                                                                 
                                                                0 MG/KG                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (51)         (50)                                                             
      Aorta, Inflammation, Chronic Active              1 (2%)                                                                       
   Heart                                              (51)         (50)                                                             
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Mineralization                                   2 (4%)       2 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (51)         (49)                                                             
      Hyperplasia                                      1 (2%)       2 (4%)                                                          
      Hypertrophy                                                   1 (2%)                                                          
   Adrenal Medulla                                    (51)         (49)                                                             
      Hyperplasia                                      3 (6%)                                                                       
   Islets, Pancreatic                                 (51)         (50)                                                             
      Hyperplasia                                      1 (2%)                                                                       
   Pituitary Gland                                    (50)         (46)                                                             
      Pars Distalis, Hyperplasia                      24 (48%)      1 (2%)                                                          
      Pars Intermedia, Hyperplasia                                  1 (2%)                                                          
   Thyroid Gland                                      (51)         (50)                                                             
      Inflammation, Chronic Active                     1 (2%)       1 (2%)                                                          
      Follicular Cell, Hyperplasia                    16 (31%)      2 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ovary                                              (51)         (50)                                                             
      Atrophy                                                       1 (2%)                                                          
      Cyst                                            16 (31%)     13 (26%)                                                         
      Hemorrhage                                                    1 (2%)                                                          
   Uterus                                             (51)         (50)                                                             
      Hyperplasia, Cystic                             38 (75%)     16 (32%)                                                         
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Inflammation, Suppurative                                     1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    3                                                              
NTP Experiment-Test: 05121-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 03/15/95  
Route: GAVAGE                                                                                                     Time: 17:07:00  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      RTD                                                                 
                                                                0 MG/KG                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (51)         (50)                                                             
      Myelofibrosis                                   22 (43%)      7 (14%)                                                         
      Erythroid Cell, Hyperplasia                      3 (6%)                                                                       
      Myeloid Cell, Hyperplasia                        9 (18%)      1 (2%)                                                          
   Lymph Node, Mandibular                             (50)         (50)                                                             
      Hyperplasia, Lymphoid                            1 (2%)       1 (2%)                                                          
   Spleen                                             (51)         (50)                                                             
      Depletion Lymphoid                               2 (4%)                                                                       
      Hematopoietic Cell Proliferation                17 (33%)      3 (6%)                                                          
      Hyperplasia, Lymphoid                            3 (6%)       1 (2%)                                                          
      Hyperplasia, Plasma Cell                         1 (2%)                                                                       
   Thymus                                             (48)         (45)                                                             
      Atrophy                                          3 (6%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (51)         (50)                                                             
      Hyperplasia                                      1 (2%)                                                                       
   Skin                                               (51)         (50)                                                             
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Ulcer                                            1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (51)         (50)                                                             
      Infarct                                          1 (2%)                                                                       
      Neuron, Necrosis                                 1 (2%)                                                                       
   Peripheral Nerve                                   (2)                                                                           
      Degeneration                                     2 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (51)         (50)                                                             
      Infiltration Cellular, Histiocyte                             2 (4%)                                                          
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                              1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    4                                                              
NTP Experiment-Test: 05121-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 03/15/95  
Route: GAVAGE                                                                                                     Time: 17:07:00  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE FEMALE                        0 MG/KG      RTD                                                                 
                                                                0 MG/KG                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (2)                                                                           
      Cornea, Inflammation, Chronic Active             2 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (51)         (50)                                                             
      Cyst                                             1 (2%)                                                                       
      Infarct                                          1 (2%)                                                                       
      Nephropathy                                     23 (45%)     16 (32%)                                                         
      Renal Tubule, Necrosis                                        1 (2%)                                                          
      Renal Tubule, Necrosis, Acute                    1 (2%)                                                                       
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    5                                                              
NTP Experiment-Test: 05121-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 03/15/95  
Route: GAVAGE                                                                                                     Time: 17:07:00  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      RTD                                                                 
                                                                0 MG/KG                                                             
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          70           60                                                               
  Early Deaths                                                                                                                      
    Natural Death                                      5            1                                                               
    Moribund Sacrifice                                 4                                                                            
  Survivors                                                                                                                         
    Natural Death                                      1                                                                            
    Terminal Sacrifice                                40           49                                                               

  Animals Examined Microscopically                    50           50                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)                                                             
      Cyst                                             1 (2%)                                                                       
      Periesophageal Tissue, Inflammation,                                                                                          
          Suppurative                                  1 (2%)       1 (2%)                                                          
   Intestine Small, Jejunum                           (50)         (50)                                                             
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
   Liver                                              (50)         (50)                                                             
      Basophilic Focus                                 3 (6%)                                                                       
      Clear Cell Focus                                12 (24%)      1 (2%)                                                          
      Eosinophilic Focus                              21 (42%)      1 (2%)                                                          
      Fatty Change                                     1 (2%)                                                                       
      Hematopoietic Cell Proliferation                 2 (4%)                                                                       
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Mixed Cell Focus                                 5 (10%)                                                                      
      Necrosis                                         1 (2%)       1 (2%)                                                          
      Bile Duct, Hyperplasia, Cystic                                1 (2%)                                                          
   Mesentery                                          (4)          (1)                                                              
      Fibrosis                                                      1 (100%)                                                        
      Fat, Necrosis                                    2 (50%)                                                                      
   Pancreas                                           (50)         (50)                                                             
      Atrophy                                          2 (4%)                                                                       
   Stomach, Forestomach                               (50)         (50)                                                             
      Hyperplasia, Focal                               3 (6%)      38 (76%)                                                         
   Stomach, Glandular                                 (50)         (50)                                                             
      Dysplasia                                                     1 (2%)                                                          
   Tongue                                                          (1)                                                              
      Mineralization                                                1 (100%)                                                        
   Tooth                                              (14)         (2)                                                              
      Dysplasia                                       13 (93%)      2 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    6                                                              
NTP Experiment-Test: 05121-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 03/15/95  
Route: GAVAGE                                                                                                     Time: 17:07:00  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      RTD                                                                 
                                                                0 MG/KG                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)                                                             
      Mineralization                                   2 (4%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)                                                             
      Accessory Adrenal Cortical Nodule                1 (2%)       2 (4%)                                                          
      Hyperplasia                                     23 (46%)     14 (28%)                                                         
      Capsule, Hyperplasia, Adenomatous                7 (14%)      6 (12%)                                                         
   Adrenal Medulla                                    (49)         (50)                                                             
      Inflammation, Chronic Active                     1 (2%)                                                                       
   Islets, Pancreatic                                 (50)         (50)                                                             
      Hyperplasia                                     29 (58%)      1 (2%)                                                          
   Pituitary Gland                                    (48)         (48)                                                             
      Pars Distalis, Hyperplasia                       1 (2%)                                                                       
   Thyroid Gland                                      (50)         (50)                                                             
      Follicular Cell, Hyperplasia                    13 (26%)      1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (50)                                                             
      Granuloma Sperm                                  1 (2%)                                                                       
   Preputial Gland                                    (50)         (50)                                                             
      Inflammation, Chronic Active                     1 (2%)       2 (4%)                                                          
      Duct, Ectasia                                   47 (94%)     24 (48%)                                                         
   Seminal Vesicle                                    (50)         (50)                                                             
      Inflammation, Chronic Active                     1 (2%)                                                                       
   Testes                                             (50)         (50)                                                             
      Atrophy                                          2 (4%)       1 (2%)                                                          
      Hypoplasia                                                    1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)                                                             
      Myeloid Cell, Hyperplasia                        1 (2%)                                                                       
   Lymph Node                                         (2)                                                                           
      Mediastinal, Hyperplasia, Lymphoid               1 (50%)                                                                      
   Lymph Node, Mesenteric                             (48)         (50)                                                             

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    7                                                              
NTP Experiment-Test: 05121-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 03/15/95  
Route: GAVAGE                                                                                                     Time: 17:07:00  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      RTD                                                                 
                                                                0 MG/KG                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Hematopoietic Cell Proliferation                 2 (4%)                                                                       
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
   Spleen                                             (50)         (50)                                                             
      Angiectasis                                      1 (2%)                                                                       
      Hematopoietic Cell Proliferation                 8 (16%)      2 (4%)                                                          
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
   Thymus                                             (42)         (45)                                                             
      Atrophy                                          6 (14%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (50)         (50)                                                             
      Subcutaneous Tissue, Lymphangiectasis            1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)                                                             
      Neuron, Necrosis                                 1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)                                                             
      Bronchiectasis, Focal                                         1 (2%)                                                          
      Embolus                                          1 (2%)                                                                       
      Inflammation, Suppurative                        1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                 8 (16%)      5 (10%)                                                         
   Nose                                               (50)         (50)                                                             
      Respiratory Epithelium, Inflammation,                                                                                         
          Chronic Active                                            1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Harderian Gland                                    (16)         (22)                                                             
      Hyperplasia                                      1 (6%)       1 (5%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    8                                                              
NTP Experiment-Test: 05121-99         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                SCOPOLAMINE HYDROBROMIDE TRIHYDRATE                            Date: 03/15/95  
Route: GAVAGE                                                                                                     Time: 17:07:00  
____________________________________________________________________________________________________________________________________

         B6C3F1 MICE MALE                          0 MG/KG      RTD                                                                 
                                                                0 MG/KG                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)                                                             
      Cyst                                             6 (12%)                                                                      
      Inflammation, Chronic Active                     2 (4%)                                                                       
      Nephropathy                                     48 (96%)     47 (94%)                                                         
      Renal Tubule, Hyperplasia                                     1 (2%)                                                          
   Urinary Bladder                                    (50)         (50)                                                             
      Inflammation, Chronic Active                     2 (4%)                                                                       
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    9                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------